Though we found ex vivo expanded CD4+ and CD8+ T cells derived from PBMCs or TILs capable of LAIR2 secretion (Figure 2B and Figure 4C), selective expression by tumor-associated Treg cells in situ suggests that the tumor microenvironment may have a role in regulating LAIR2 expression. The gene discussed is CD8A; the disease is neoplasm.